Home › Trial NCT01488552
Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
- Trial IDNCT01488552
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorPancreatic Cancer Research Team
- Enrollment60
- Start date2011-11
- ConditionsStage IV Pancreatic Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.